Shared Decision-Making for Advanced Renal Cell Carcinoma: Focus on Adverse Event Management of Axitinib Plus IO: A Vodcast
Abstract Shared decision-making is essential to the care of patients with advanced renal carcinoma which can empower patients and help the healthcare team understand the patient’s goals of care. An important topic during the shared-decision making process is identification and management of treatmen...
Saved in:
| Main Authors: | Edwin M. Posadas, Nancy Moldawer, Greg Biddulph, Dharanija Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Oncology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40487-025-00330-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast
by: Benjamin Garmezy, et al.
Published: (2024-10-01) -
Phase Separation Investigation of Axitinib in Supersaturated Solution
by: Jie Xu, et al.
Published: (2024-11-01) -
Significant response to toripalimab plus axitinib for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report and literature review
by: Xin Chen, et al.
Published: (2025-08-01) -
N‐Acetyl‐L‐Cysteine (NAC) Blunts Axitinib‐Related Adverse Effects in Preclinical Models of Glioblastoma
by: Alessia Formato, et al.
Published: (2024-10-01) -
Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study
by: Zhongjie Zhao, et al.
Published: (2025-01-01)